Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of a naltrexone hydrochloride implant for alcohol use disorder; recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone hydrochloride implant (naltrexone hydrochloride implant)

Snippet

Sponsor: Shenzhen Sciencare Medical Industries Co., Ltd. | Conditions: Alcohol Use Disorder (AUD) | Phase 3 | Status: NOT_YET_RECRUITING